Fast track for antiretroviral.
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D044966:Anti-Retroviral Agents; D000911:Antibodies, Monoclonal; C481504:ibalizumab